Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Advances in small molecules promoting neurotrophic function.

Raymond D Price1, Stuart A Milne, John Sharkey

  • 1Pharmacology Research Laboratories, Astellas Pharma Inc., 21 Miyukigaoka, Tsukuba 305-8585, Japan. raymond.price@acucela.com

Pharmacology & Therapeutics
|June 30, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stochastic Nature of Fascia: From Layered Pedagogical Artifact to Morphogenetic Reality in Clinical Anatomy.

Life (Basel, Switzerland)·2025
Same author

Calcium Unified: Understanding How Calcium's Atomic Properties Impact Human Health.

Cells·2025
Same author

Relief of benign paroxysmal positional vertigo and temporomandibular disorder using a myofascial induction in genu recurvatum patients: Case reports.

Journal of bodywork and movement therapies·2024
Same author

Fabrication of a graphite-paraffin carbon paste electrode and demonstration of its use in electrochemical detection strategies.

The Analyst·2024
Same author

Interdisciplinary Management of Extramammary Paget's Disease Using Mohs Micrographic Surgery With Frozen Section Cytokeratin-7 Immunostains.

Urology·2022
Same author

Extract of Scutellaria baicalensis induces semaphorin 3A production in human epidermal keratinocytes.

PloS one·2021

Small molecules offer promising therapeutic potential for neurological diseases by mimicking nerve growth factor (NGF) signaling. These compounds may overcome limitations of direct neurotrophin use, showing promise in clinical development.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Drug Development

Background:

  • Neurotrophins, like nerve growth factor (NGF), are vital for neuronal survival and differentiation.
  • Their therapeutic use is hindered by poor pharmacokinetics and side effects.
  • Modulating neurotrophin pathways presents an alternative therapeutic strategy.

Purpose of the Study:

  • To review clinical trials of direct neurotrophin modulators.
  • To explore alternative strategies targeting neurotrophin production and signaling pathways.
  • To emphasize small molecules for modulating neurotrophin function in nervous system diseases.

Main Methods:

  • Review of clinical trial progress for direct neurotrophin modulators.
  • Description of alternative strategies targeting neurotrophin pathways.

Related Experiment Videos

  • Focus on small molecules for neurotrophin modulation.

    • Main Results:

    • Direct neurotrophin use faces pharmacokinetic and side-effect challenges.
    • Alternative strategies, particularly small molecules, show promise in preclinical studies.
    • Some small molecule approaches are advancing into clinical development.

    Conclusions:

    • Small molecules modulating neurotrophin function are a viable therapeutic concept.
    • Existing drugs like antidepressants can influence neurotrophin pathways.
    • Targeting neurotrophin signaling via small molecules holds potential for treating nervous system disorders.